Solas BioVentures Emerging Healthcare Fund, LP — Form D
Solas BioVentures Emerging Healthcare Fund, LP of CHATTANOOGA, TN, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2022-11-03. $5.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-11-03
- Form: D
- Accession: 0001951635-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $5.8M
- Minimum investment: $5.0M
- Investors: 1
- Date of first sale: 2022-10-21
- Security types: fund interests
- SEC file number: 021-463813
Issuer
- Name: Solas BioVentures Emerging Healthcare Fund, LP
- CIK: 0001940916
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 412 GEORGIA AVENUE, CHATTANOOGA, TN, 37403
- Phone: (423) 243-3460
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| David Belitz | Executive Officer | Arden Hills, MN |
| David Belitz | Promoter | Arden Hills, MN |
| n/a na Solas BioVentures Management, LLC | Promoter | CHATTANOOGA, TN |
| Michael Hoey | Executive Officer | Maple Grove, MN |
| Michael Hoey | Promoter | Maple Grove, MN |
| n/a na Solas BioVentures Emerging Healthcare GP, LLC | Promoter | Chattanooga, TN |
| David C Adair | Executive Officer | Chattanooga, TN |
| David C Adair | Promoter | Chattanooga, TN |
| Mark D Hackett | Executive Officer | Chattanooga, TN |
| Mark D Hackett | Promoter | Chattanooga, TN |
Other filings by this issuer (2)
More